Related Experiment Video
Updated: Aug 10, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
[Drugs against human cytomegalovirus]
Zbigniew J Leśnikowski1, Edyta Paradowska, Marzena Przepiórkiewicz
1Department of Virology, Royal Free and University College Medical School, London. zlesnik@wirus.cmiwpan.lodz.pl
Human cytomegalovirus (HCMV) is common, often asymptomatic in healthy individuals. However, it poses significant risks to immunocompromised patients and can cause severe congenital infections in newborns, necessitating new antiviral treatments.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Human cytomegalovirus (HCMV) is a widespread herpesvirus, infecting a majority of the global population.
- While typically asymptomatic in immunocompetent individuals, HCMV can cause severe disease in immunocompromised hosts, including transplant recipients and HIV-infected patients.
- Congenital HCMV infection is a significant concern, affecting a notable percentage of live births and leading to potential developmental issues in infants.
Purpose of the Study:
- To review current anti-HCMV drugs in clinical use.
- To highlight novel antiviral molecules currently under laboratory and clinical development.
- To provide an overview of the therapeutic landscape for HCMV infections.
Main Methods:
- Literature review of existing anti-HCMV therapies.
- Survey of emerging antiviral agents in preclinical and clinical trials.
- Synthesis of information on drug efficacy and development status.
Main Results:
- Several antiviral drugs are currently approved for HCMV treatment.
- A pipeline of new anti-HCMV drug candidates is under investigation.
- The development of novel therapies aims to address unmet needs in managing HCMV infections.
Conclusions:
- Effective antiviral strategies are crucial for managing HCMV in vulnerable populations.
- Ongoing research into new anti-HCMV drugs offers hope for improved patient outcomes.
- A comprehensive understanding of current and future treatments is vital for clinicians and researchers.
More Related Videos
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
DNA Base Pairing
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly